Takao Sanaki

6PUBLICATIONS
21CO-AUTHORS
Medical virologyBiologically active moleculesMolecular targetsGene and molecular therapyMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 08, 2022
Efficacy and Safety of Ensitrelvir in Patients With Mild-to-Moderate Coronavirus Disease 2019: The Phase 2b Part of a Randomized, Placebo-Controlled, Phase 2/3 Study.

Hiroshi Mukae, Hiroshi Yotsuyanagi, Norio Ohmagari

|Nov 03, 2022
S-217622, a SARS-CoV-2 main protease inhibitor, decreases viral load and ameliorates COVID-19 severity in hamsters.

Michihito Sasaki, Koshiro Tabata, Mai Kishimoto

|Aug 01, 2022
Efficacy of ensitrelvir against SARS-CoV-2 in a delayed-treatment mouse model.

Haruaki Nobori, Keita Fukao, Takayuki Kuroda

|Jan 22, 2022
Characterization of the In Vitro and In Vivo Efficacy of Baloxavir Marboxil against H5 Highly Pathogenic Avian Influenza Virus Infection.

Keiichi Taniguchi, Yoshinori Ando, Masanori Kobayashi

|Mar 06, 2021
TMPRSS11D and TMPRSS13 Activate the SARS-CoV-2 Spike Protein.

Mai Kishimoto, Kentaro Uemura, Takao Sanaki

|Jan 21, 2021
SARS-CoV-2 variants with mutations at the S1/S2 cleavage site are generated in vitro during propagation in TMPRSS2-deficient cells.

Michihito Sasaki, Kentaro Uemura, Akihiko Sato

Pageof 1

Frequent Collaborators

3 joint publications

Michihito Sasaki

3 joint publications

Yasuko Orba

3 joint publications

Haruaki Nobori

2 joint publications

Hirofumi Sawa